MetabolismNews.net

Metabolism Xagena

Xagena Mappa
Medical Meeting
Farmaexplorer.it
Ematobase.it

Search results for "Type 2 diabetes mellitus"

On 18 October 2012, the Committee for Medicinal Products for Human Use ( CHMP ) adopted a negative opinion, recommending the refusal of the marketing authorisation for the medicinal product Qsiva, int ...


In short-term randomized trials ( duration, 1 to 2 years ), bariatric surgery has been associated with improvement in type 2 diabetes mellitus. Researchers have assessed outcomes 3 years after the ...


The European Medicines Agency ( EMA ) has recommended granting a marketing authorisation for Mysimba ( Naltrexone / Bupropion ) for weight management of overweight or obese adults. The medicine is rec ...


Metabolic surgery is a novel therapy for mild obesity ( BMI 30-35 Kg/m2 ) in type 2 diabetes mellitus ( T2DM ) patients. The ABCD score, which comprise age, BMI, C-peptide level, and duration of type ...


In humans, developing metabolic disease, particularly type 2 diabetes, is correlated with having bacteria that penetrate the mucus lining of the colon. The findings, which provide insight on how pe ...